Share chart ResMed
Extended chart
Simple chart
About ResMed
ResMed является калифорнийской компанией по производству медицинского оборудования. В первую очередь это касается оборудования, связанного с лечением нарушений дыхания, связанных со сном, включая апноэ во сне, хроническую обструктивную болезнь легких и другие респираторные заболеванияIPO date | 1995-06-02 |
---|---|
ISIN | US7611521078 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0.8553 |
Дивиденд ао | 2.6 |
Сайт | http://www.resmed.com |
Цена ао | 214.53 |
Change price per day: | 0% (214.53) |
---|---|
Change price per week: | +4.88% (204.54) |
Change price per month: | -4.3% (224.16) |
Change price per 3 month: | -6.25% (228.83) |
Change price per half year: | -9.99% (238.34) |
Change price per year: | +15.91% (185.09) |
Change price per 3 year: | +7.12% (200.28) |
Change price per 5 year: | +1.66% (211.02) |
Change price per 10 year: | +268.73% (58.18) |
Change price per year to date: | -7.76% (232.58) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Vanguard Group Inc | 17743457 | 12.06 |
Blackrock Inc. | 12248180 | 8.33 |
State Street Corporation | 6290089 | 4.28 |
Geode Capital Management, LLC | 3435280 | 2.34 |
FMR, LLC | 2529218 | 1.72 |
Invesco Ltd. | 1947175 | 1.32 |
Morgan Stanley | 1744028 | 1.19 |
Northern Trust Corporation | 1451951 | 0.99 |
Norges Bank Investment Management | 1360110 | 0.92 |
Bank Of New York Mellon Corporation | 1154410 | 0.78 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Global X Telemedicine & Digital Health ETF Registered | 4.81893 | 2.72 | 0.28226 |
ERShares Entrepreneurs ETF | 3.47445 | 26.58 | 0.14097 |
Collaborative Investment Series Trust - Mohr Growth ETF | 1.16591 | -0.8238 | 0.8837 |
Donoghue Forlines Innovation ETF | 0.88026 | 0.9622 | 0.89556 |
iShares Morningstar Mid-Cap Growth ETF | 0.66934 | 436.83 | 0.94237 |
FCF US Quality ETF | 0.40782 | 15.8 | 1.58997 |
iShares Morningstar Mid-Cap ETF | 0.3335 | 249.32 | 1.7458 |
iShares Morningstar Large-Cap Growth ETF | 0.14798 | 277.75 | 0.5823 |
iShares Morningstar Large-Cap ETF | 0.0719 | 257.57 | 1.41244 |
![]() |
0.07 | 54.54 | |
Columbia U.S. ESG Equity Income ETF | 0.06468 | -99.18 | 1.44131 |
1.1 | 111.1 | 0.9 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Michael J. Farrell BE, MBA, SM | CEO & Chairman | 2.87M | 1972 (53 years) |
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Director | 430.21k | 1942 (83 years) |
Mr. Brett A. Sandercock | Chief Financial Officer | 909.64k | 1967 (58 years) |
Mr. Robert A. Douglas | Special Advisor | 1.91M | 1960 (65 years) |
Mr. Kaushik Ghoshal | Chief Commercial Officer - SaaS | 1.11M | 1969 (56 years) |
Ms. Amy Wakeham | Chief Investor Relations Officer | N/A | |
Mr. Michael J. Rider | Chief Legal Officer | N/A | 1958 (67 years) |
Mr. Jim Ellis | Chief Compliance Officer | N/A | |
Ms. Yvonne-Katrin Pucknat | Chief Marketing Officer | N/A | |
Mr. Alastair Robertson | Chief Information Officer |
Address: United States, San Diego, CA , 9001 Spectrum Center Boulevard - open in Google maps, open in Yandex maps
Website: http://www.resmed.com
Website: http://www.resmed.com